Phase II study of alemtuzumab in chronic lymphoproliferative disorders

Alessandra Ferrajoli, Susan M. O'Brien, Jorge E. Cortes, Francis J. Giles, Deborah A. Thomas, Stefan Faderl, Razelle Kurzrock, Susan Lerner, Dimitrios P. Kontoyiannis, Michael J. Keating

Research output: Contribution to journalArticlepeer-review

122 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of alemtuzumab in chronic lymphoproliferative disorders'. Together they form a unique fingerprint.

Medicine & Life Sciences